Medicina-
Oncology Xagena Newsoncologyonline.netPatients with stage III colon cancer treated with Leucovorin, Fluorouracil, and Oxaliplatin with or without Cetuximab: prognostic effect of BRAF and KRAS mutations
Oncology Xagena News – oncologyonline.netwww.oncologyonline.net/?q=CabozantinibCABOSUN trial: Cabozantinib has improved progression-free survival versus Sunitinib, decreasing the rate of disease progression or death by 31%
Oncologia – Farmaci - Xagenaoncologia.xagena.it/farmaciLa terapia transdermica locale alla mammella può permettere il trasporto mirato del farmaco, e nello stesso tempo riduce le reazioni …